RESUMEN
BACKGROUND: Zinc is an essential micronutrient for human health. Approximately 1.4% of deaths worldwide are related to zinc deficiency. In Mexico, 33% of children younger than 5 years are zinc deficient. OBJECTIVE: To give an overview of zinc supplementation and fortification in children younger than 5 years through the analysis of current regulations in Mexico, the availability of these products, and the opinion of Mexican experts in this field. METHODS: We gave an overview of zinc supplementation and fortification strategies in the Mexican pediatric population by conducting a literature review of Mexican studies and national standards concerning zinc supplementation and fortification. Semistructured interviews were conducted with personnel from the main producers of zinc supplements and fortified products and from social assistance programs in Mexico. RESULTS: Zinc supplementation in Mexico has been associated with reduction in the duration and incidence of diarrhea. Through interviews with experts, we identified several barriers in achieving adequate zinc consumption such as problems in social assistance programs that distribute zinc-fortified foods, lack of specific dietary recommendations regarding the intake of zinc, lack of regulation of nonpatented zinc supplements, and inconsistencies in public health actions due to political and administrative changes. CONCLUSION: Despite current regulation and efforts made by social assistance programs, zinc deficiency continues to be a prevalent public health issue. Mexico requires an in-depth analysis of existing barriers and alternatives in order to reduce zinc deficiency.
Asunto(s)
Suplementos Dietéticos , Alimentos Fortificados/estadística & datos numéricos , Política Nutricional/legislación & jurisprudencia , Ingesta Diaria Recomendada/legislación & jurisprudencia , Zinc/deficiencia , Preescolar , Femenino , Humanos , Masculino , México , Prevalencia , Zinc/administración & dosificaciónRESUMEN
This work aims at giving an updated picture of the strict interaction between main plant biologically active compounds and botanicals. The main features of the emerging class of dietary supplements, the botanicals, are highlighted. Focus is also on the definition of actual possibilities of study approach and research strategies. Examples of innovative directions are given: assessment of interaction of bioactive compounds, chemometrics and the new goal of biorefineries. Current models of existing databases, such as plant metabolic pathways, food composition, bioactive compounds, dietary supplements, and dietary markers, are described as usable tools for health research. The need for categorization of botanicals as well as for the implementation of specific and dedicated databases emerged, based on both analytical data and collected data taken from literature throughout a harmonized and standardized approach for the evaluation of an adequate dietary intake.
Asunto(s)
Suplementos Dietéticos/análisis , Fitoquímicos/análisis , Preparaciones de Plantas/normas , Plantas/química , Código de Barras del ADN Taxonómico/métodos , Bases de Datos Factuales/provisión & distribución , Suplementos Dietéticos/normas , Humanos , Fitoquímicos/administración & dosificación , Fitoquímicos/normas , Plantas/clasificación , Plantas/genética , Ingesta Diaria Recomendada/legislación & jurisprudencia , Proyectos de Investigación , Medición de Riesgo , Terminología como AsuntoRESUMEN
Abstracts: Adequate intakes of fat-soluble vitamins are essential to support the growth and development of the foetus, the neonate, and the young child. By means of an online self-administered frequency questionnaire, this study aimed to evaluate the intake of vitamins A, D, E, and K in Belgian infants (n = 455), toddlers (n = 265), pregnant women (n = 161), and lactating women (n = 165). The contribution of foods, fortified foods, and supplements on the total intake was quantified. 5% of toddlers, 16% of pregnant women, and 35% of lactating women had an inadequate vitamin A intake. Conversely, excessive vitamin A intakes were associated with consumption of liver (products). Furthermore, 22% of infants were at risk for inadequate vitamin D intake due to the lack of prophylaxis, while consumption of highly dosed supplements posed a risk for excessive intakes in 6%-26% of infants. Vitamin D intake in pregnant women and lactating women was inadequate (median of 51%, respectively, 60% of the adequate intake). In all groups, the risk for inadequate intake of vitamin E and K was low. Contribution of fortified foods to vitamin A, D, E, and K intake was minor, except in toddlers. National fortification strategies should be investigated as an alternative or additional strategy to prevent vitamin D and A deficiency. There is a need to revise and set uniform supplement recommendations. Finally, non-users of vitamin D prophylaxis need to be identified for targeted treatment.
Asunto(s)
Fenómenos Fisiológicos Nutricionales Infantiles , Suplementos Dietéticos , Alimentos Fortificados , Lactancia , Fenómenos Fisiologicos Nutricionales Maternos , Estado Nutricional , Ingesta Diaria Recomendada , Vitaminas/administración & dosificación , Avitaminosis/etiología , Avitaminosis/prevención & control , Preescolar , Encuestas sobre Dietas , Femenino , Humanos , Lactante , Fenómenos Fisiológicos Nutricionales del Lactante , Recién Nacido , Masculino , Embarazo , Ingesta Diaria Recomendada/legislación & jurisprudencia , Solubilidad , Vitamina A/administración & dosificación , Vitamina D/administración & dosificación , Vitamina E/administración & dosificación , Vitamina K/administración & dosificación , Vitaminas/químicaRESUMEN
BACKGROUND: The nutrition societies of Germany, Austria and Switzerland have revised the reference values for potassium intake in January 2017. METHODS: For adults, the estimated value was based on the 24-h urinary potassium excretion and on preventive considerations regarding hypertension and stroke. The estimated values for children and adolescents were extrapolated from the adult estimated value considering differences in body mass. For infants aged 0 to under 4 months, the estimated value was set based on the potassium intake via breast milk. From this reference value, the estimated value for infants aged 4 to under 12 months was also derived by extrapolation. The estimated value for lactating women takes into account the potassium loss via breast milk. RESULTS: The estimated values for potassium intake are set at 400 mg/day for breastfed infants aged 0 to under 4 months, 600 mg/day for infants aged 4 to under 12 months, 1,100-4,000 mg/day for children and adolescents, 4,000 mg/day for adults and pregnant women and 4,400 mg/day for lactating women. CONCLUSIONS: The consumption of potassium-rich foods should be generally increased. Supplemental intake beyond the estimated values has no health benefit and is therefore not recommended.
Asunto(s)
Hipertensión/epidemiología , Potasio en la Dieta/administración & dosificación , Potasio en la Dieta/normas , Ingesta Diaria Recomendada/legislación & jurisprudencia , Adolescente , Adulto , Anciano , Austria/epidemiología , Niño , Preescolar , Dieta , Femenino , Análisis de los Alimentos , Alemania/epidemiología , Humanos , Hipertensión/prevención & control , Lactante , Masculino , Persona de Mediana Edad , Potasio en la Dieta/orina , Prevalencia , Valores de Referencia , Suiza/epidemiología , Adulto JovenAsunto(s)
Suplementos Dietéticos , Ácido Fólico/administración & dosificación , Conocimientos, Actitudes y Práctica en Salud , Defectos del Tubo Neural/prevención & control , Ingesta Diaria Recomendada/legislación & jurisprudencia , Adolescente , Adulto , Concienciación , Femenino , Humanos , Japón , Guías de Práctica Clínica como Asunto , Atención Preconceptiva/legislación & jurisprudencia , Encuestas y CuestionariosAsunto(s)
Suplementos Dietéticos , Ácido Fólico/administración & dosificación , Defectos del Tubo Neural/prevención & control , Ingesta Diaria Recomendada/legislación & jurisprudencia , Sociedades Médicas/legislación & jurisprudencia , Adulto , Femenino , Humanos , Japón , Riesgo , Teratología/educaciónAsunto(s)
Etiquetado de Alimentos/normas , Ingesta Diaria Recomendada , Calcio de la Dieta/normas , Bebidas Gaseosas/normas , Bebidas Gaseosas/provisión & distribución , Comercio , Sacarosa en la Dieta/administración & dosificación , Sacarosa en la Dieta/normas , Ingestión de Energía , Etiquetado de Alimentos/legislación & jurisprudencia , Humanos , Potasio en la Dieta/administración & dosificación , Potasio en la Dieta/normas , Ingesta Diaria Recomendada/legislación & jurisprudencia , Tamaño de la Porción de Referencia/normas , Edulcorantes/administración & dosificación , Edulcorantes/normas , Ácidos Grasos trans/administración & dosificación , Ácidos Grasos trans/normas , Estados Unidos , United States Food and Drug AdministrationRESUMEN
BACKGROUND: There are no internationally agreed recommendations on compositional requirements of follow-up formula for young children (FUF-YC) aged 1-3 years. AIM: The aim of the study is to propose international compositional recommendations for FUF-YC. METHODS: Compositional recommendations for FUF-YC were devised by expert consensus based on a detailed literature review of nutrient intakes and unmet needs in children aged 12-36 months. RESULTS AND CONCLUSIONS: Problematic nutrients with often inadequate intakes are the vitamins A, D, B12, C and folate, calcium, iron, iodine and zinc. If used, FUF-YC should be fed along with an age-appropriate mixed diet, usually contributing 1-2 cups (200-400 ml) of FUF-YC daily (approximately 15% of total energy intake). Protein from cow's milk-based formula should provide 1.6-2.7 g/100 kcal. Fat content should be 4.4-6.0 g/100 kcal. Carbohydrate should contribute 9-14 g/100 kcal with >50% from lactose. If other sugars are added, they should not exceed 10% of total carbohydrates. Calcium should provide 200 mg/100 kcal. Other micronutrient contents/100 kcal should reach 15% of the World Health Organization/Food and Agriculture Organization recommended nutrient intake values. A guidance upper level that was 3-5 times of the minimum level was established. Countries may adapt compositional requirements, considering recommended nutrient intakes, habitual diets, nutritional status and existence of micronutrient programs to ensure adequacy while preventing excessive intakes.
Asunto(s)
Fórmulas Infantiles/química , Fórmulas Infantiles/normas , Fenómenos Fisiológicos Nutricionales del Lactante/normas , Academias e Institutos , Preescolar , Carbohidratos de la Dieta/análisis , Grasas de la Dieta/análisis , Ingestión de Energía , Estudios de Seguimiento , Humanos , Lactante , Lactosa/administración & dosificación , Lactosa/análisis , Micronutrientes/análisis , Micronutrientes/deficiencia , Proteínas de la Leche/administración & dosificación , Proteínas de la Leche/análisis , Estado Nutricional , Ensayos Clínicos Controlados Aleatorios como Asunto , Ingesta Diaria Recomendada/legislación & jurisprudencia , TailandiaRESUMEN
The effect of roasting of coffee beans and the extraction of ground coffee with different volumes of hot pressurised water on the caffeine and the total caffeoylquinic acids (CQAs) content of the resultant beverages was investigated. While caffeine was stable higher roasting temperatures resulted in a loss of CQAs so that the caffeine/CQA ratio was a good marker of the degree of roasting. The caffeine and CQA content and volume was determined for 104 espresso coffees obtained from coffee shops in Scotland, Italy and Spain, limited numbers of cappuccino coffees from commercial outlets and several instant coffees. The caffeine content ranged from 48-317 mg per serving and CQAs from 6-188 mg. It is evident that the ingestion of 200 mg of caffeine per day can be readily and unwittingly exceeded by regular coffee drinkers. This is the upper limit of caffeine intake from all sources recommended by US and UK health agencies for pregnant women. In view of the variable volume of serving sizes, it is also clear that the term "one cup of coffee" is not a reproducible measurement for consumption, yet it is the prevailing unit used in epidemiology to assess coffee consumption and to link the potential effects of the beverage and its components on the outcome of diseases. More accurate measurement of the intake of coffee and its potentially bioactive components are required if epidemiological studies are to produce more reliable information.
Asunto(s)
Cafeína/análisis , Ácido Clorogénico/análisis , Café/química , Coffea/química , Coffea/clasificación , Italia , Límite de Detección , Ácido Quínico/análogos & derivados , Ácido Quínico/análisis , Ingesta Diaria Recomendada/legislación & jurisprudencia , Escocia , EspañaRESUMEN
PURPOSE: At northern latitudes, vitamin D is not synthesized endogenously during winter, causing low plasma 25-hydroxyvitamin D (25(OH)D) concentrations. Therefore, we evaluated the effects of a healthy Nordic diet based on Nordic nutrition recommendations (NNR) on plasma 25(OH)D and explored its dietary predictors. METHODS: In a Nordic multi-centre trial, subjects (n = 213) with metabolic syndrome were randomized to a control or a healthy Nordic diet favouring fish (≥300 g/week, including ≥200 g/week fatty fish), whole-grain products, berries, fruits, vegetables, rapeseed oil and low-fat dairy products. Plasma 25(OH)D and parathyroid hormone were analysed before and after 18- to 24-week intervention. RESULTS: At baseline, 45 % had vitamin D inadequacy (<50 nmol/l), whereas 8 % had deficiency (<25 nmol/l). Dietary vitamin D intake was increased by the healthy Nordic diet (P < 0.001). The healthy Nordic and the control diet reduced the prevalence of vitamin D inadequacy by 42 % (P < 0.001) and 19 % (P = 0.002), respectively, without between-group difference (P = 0.142). Compared with control, plasma 25(OH)D (P = 0.208) and parathyroid hormone (P = 0.207) were not altered by the healthy Nordic diet. Predictors for 25(OH)D were intake of vitamin D, eicosapentaenoic acids (EPA), docosahexaenoic acids (DHA), vitamin D supplement, plasma EPA and plasma DHA. Nevertheless, only vitamin D intake and season predicted the 25(OH)D changes. CONCLUSION: Consuming a healthy Nordic diet based on NNR increased vitamin D intake but not plasma 25(OH)D concentration. The reason why fish consumption did not improve vitamin D status might be that many fish are farmed and might contain little vitamin D or that frying fish may result in vitamin D extraction. Additional ways to improve vitamin D status in Nordic countries may be needed.
Asunto(s)
Dieta , Suplementos Dietéticos , Conducta Alimentaria , Síndrome Metabólico/sangre , Vitamina D/análogos & derivados , Adulto , Anciano , Índice de Masa Corporal , Productos Lácteos , Ácidos Docosahexaenoicos/administración & dosificación , Ácidos Docosahexaenoicos/sangre , Grano Comestible , Ácido Eicosapentaenoico/administración & dosificación , Ácido Eicosapentaenoico/sangre , Ácidos Grasos Monoinsaturados , Femenino , Frutas , Humanos , Estilo de Vida , Masculino , Síndrome Metabólico/complicaciones , Persona de Mediana Edad , Evaluación Nutricional , Estado Nutricional , Hormona Paratiroidea/sangre , Aceites de Plantas , Aceite de Brassica napus , Ingesta Diaria Recomendada/legislación & jurisprudencia , Encuestas y Cuestionarios , Verduras , Vitamina D/administración & dosificación , Vitamina D/sangre , Deficiencia de Vitamina D/sangre , Deficiencia de Vitamina D/complicacionesRESUMEN
The EURopean micronutrient RECommendations Aligned (EURRECA) Network of Excellence explored the process of setting micronutrient recommendations to address the variance in recommendations across Europe. Work centered upon the transparent assessment of nutritional requirements via a series of systematic literature reviews and meta-analyses. In addition, the necessity of assessing nutritional requirements and the policy context of setting micronutrient recommendations was investigated. Findings have been presented in a framework that covers nine activities clustered into four stages: stage one "Defining the problem" describes Activities 1 and 2: "Identifying the nutrition-related health problem" and "Defining the process"; stage two "Monitoring and evaluating" describes Activities 3 and 7: "Establishing appropriate methods," and "Nutrient intake and status of population groups"; stage three "Deriving dietary reference values" describes Activities 4, 5, and 6: "Collating sources of evidence," "Appraisal of the evidence," and "Integrating the evidence"; stage four "Using dietary reference values in policy making" describes Activities 8 and 9: "Identifying policy options," and "Evaluating policy implementation." These activities provide guidance on how to resolve various issues when deriving micronutrient requirements and address the methodological and policy decisions, which may explain the current variation in recommendations across Europe. [Supplementary materials are available for this article. Go to the publisher's online edition of Critical Reviews in Food Science and Nutrition for the following free supplemental files: Additional text, tables, and figures.].
Asunto(s)
Medicina Basada en la Evidencia/métodos , Micronutrientes/normas , Política Nutricional/legislación & jurisprudencia , Ingesta Diaria Recomendada/legislación & jurisprudencia , Biomarcadores/sangre , Toma de Decisiones , Dieta/normas , Ingestión de Energía , Europa (Continente) , Humanos , Metaanálisis como Asunto , Modelos Biológicos , Evaluación Nutricional , Estado Nutricional , Estudios Observacionales como Asunto , Ensayos Clínicos Controlados Aleatorios como Asunto , Valores de Referencia , Medición de Riesgo , Factores SocioeconómicosRESUMEN
In most countries, the dietary folate intake associated with adequate status of red cell folate and/or serum folate provides the basis for formulating reference values. One of the major challenges in setting dietary reference values for folate, however, is the need to account for the differences in bioavailability between the natural forms of the vitamin and the synthetic form, folic acid, albeit to date, few countries in Europe take bioavailability into consideration. A series of systematic reviews that included only those studies which used the most robust measures of both folate intake and folate status were carried out by the EURRECA Network of Excellence to examine the relationships between folate intake, status, and a number of health outcomes relevant to specific stages of the lifecycle. This review summarizes the available evidence and the issues to consider in the setting of dietary reference values for folate.
Asunto(s)
Suplementos Dietéticos , Ácido Fólico/sangre , Estado Nutricional , Ingesta Diaria Recomendada/legislación & jurisprudencia , Disponibilidad Biológica , Dieta , Europa (Continente) , Ácido Fólico/farmacocinética , Humanos , Evaluación Nutricional , Política Nutricional , Estudios Observacionales como Asunto , Ensayos Clínicos Controlados Aleatorios como Asunto , Valores de ReferenciaRESUMEN
Iodine is an essential component of thyroid hormones, and current recommendations for intake are based on urinary iodine excretion, assessment of thyroid size, thyroidal iodine accumulation and turnover, radioactive iodine uptake, balance studies, and epidemiological studies. Dietary iodine is rapidly and almost completely absorbed. The prevalence of inadequate iodine intake is high: 29% of the world's population lives in iodine-deficient areas and 44% of Europe remains mildly iodine deficient. To assess current data and update evidence for setting dietary recommendations for iodine, the EURRECA Network of Excellence has undertaken systematic review and evaluation of (i) the usefulness of iodine status biomarkers (ii) the relationship between iodine status biomarkers and dietary iodine intake, and (iii) the relationship between iodine intake and health outcomes (endemic goiter, hypothyroidism, and cognitive function). This review summarizes the main research outputs: the key findings of the literature review, results of the meta-analyses, and discussion of the main conclusions. Currently, data for relevant intake-status-health relationships for iodine are limited, particularly for population groups such as children under two years, pregnant women, and the elderly. The EURRECA Network developed best practice guidelines for the identification of pertinent iodine studies based on a systematic review approach. This approach aimed to identify comparable data, suitable for meta-analysis, for different countries and across all age ranges. When new data are available, the EURRECA Network best practice guidelines will provide a better understanding of iodine requirements for different health outcomes which could be used to set evidence-based dietary iodine recommendations for optimal health.
Asunto(s)
Suplementos Dietéticos , Yodo/sangre , Ingesta Diaria Recomendada/legislación & jurisprudencia , Disponibilidad Biológica , Dieta , Europa (Continente) , Medicina Basada en la Evidencia , Femenino , Humanos , Yodo/farmacocinética , Metaanálisis como Asunto , Evaluación Nutricional , Política Nutricional , Estado Nutricional , Estudios Observacionales como Asunto , Embarazo , Ensayos Clínicos Controlados Aleatorios como Asunto , Valores de ReferenciaRESUMEN
Currently, a factorial approach is used to derive reference values for iron. Calculations include the use of a bioavailability factor to convert the physiological requirement, derived from obligatory losses and requirements for growth and development, into a dietary intake value. A series of systematic reviews undertaken by the EURRECA Network of Excellence aimed to identify data that may increase the accuracy of factorial calculations across all population groups. The selection of robust data was guided by the use of standardized review methodology and the evidence-based selection of status biomarkers and dietary intake assessment techniques. Results corroborated the dearth of relevant factorial data, including whole-diet bioavailability data, and confirmed the need to continue extrapolating physiological requirements across population groups. Data were also unavailable that would allow reference values to be based on selected health outcomes associated with iron intake or status. Ideally, a series of observational and randomized controlled trial (RCT) studies need to be undertaken across all population groups and life stages to generate robust data for setting dietary reference values for iron. It will also be essential to include information on polymorphisms that potentially influence iron absorption and status in the derivation process.
Asunto(s)
Suplementos Dietéticos , Hierro de la Dieta/sangre , Ingesta Diaria Recomendada/legislación & jurisprudencia , Disponibilidad Biológica , Biomarcadores/sangre , Dieta , Medicina Basada en la Evidencia , Humanos , Hierro de la Dieta/farmacocinética , Metaanálisis como Asunto , Evaluación Nutricional , Política Nutricional/legislación & jurisprudencia , Estudios Observacionales como Asunto , Ensayos Clínicos Controlados Aleatorios como Asunto , Valores de ReferenciaRESUMEN
Current reference values for selenium, an essential micronutrient, are based on the intake of selenium that is required to achieve maximal glutathione peroxidase activity in plasma or erythrocytes. In order to assess the evidence of relevance to setting dietary reference values for selenium, the EURRECA Network of Excellence focused on systematic searches, review, and evaluation of (i) selenium status biomarkers and evidence for relationships between intake and status biomarkers, (ii) selenium and health (including the effect of intake and/or status biomarkers on cancer risk, immune function, HIV, cognition, and fertility), (iii) bioavailability of selenium from the diet, and (iv) impact of genotype/single nucleotide polymorphisms on status or health outcomes associated with selenium. The main research outputs for selenium and future research priorities are discussed further in this review.
Asunto(s)
Suplementos Dietéticos , Ingesta Diaria Recomendada/legislación & jurisprudencia , Selenio/sangre , Biomarcadores/sangre , Medicina Basada en la Evidencia , Humanos , Evaluación Nutricional , Política Nutricional/legislación & jurisprudencia , Estado Nutricional , Ensayos Clínicos Controlados Aleatorios como Asunto , Valores de Referencia , Selenio/farmacocinéticaRESUMEN
The time course of the EURRECA from 2008 to 2012, overlapped considerably with the timeframe of the process undertaken by the North American Institute of Medicine (IOM) to revise dietary reference intakes for vitamin D and calcium (published November 2010). Therefore the aims of the vitamin D-related activities in EURRECA were formulated to address knowledge requirements that would complement the activities undertaken by the IOM and provide additional resources for risk assessors and risk management agencies charged with the task of setting dietary reference values for vitamin D. A total of three systematic reviews were carried out. The first, which pre-dated the IOM review process, identified and evaluated existing and novel biomarkers of vitamin D status and confirmed that circulating 25-hydroxyvitamin D (25(OH)D) concentrations is a robust and reliable marker of vitamin D status. The second systematic review conducted a meta-analysis of the dose-response of serum 25(OH)D to vitamin D intake from randomized controlled trials (RCT) among adults to explore the most appropriate model of the vitamin D intake-serum 25(OH)D) relationship to estimate requirements. The third review also carried out a meta-analysis to evaluate evidence of efficacy from RCT using foods fortified with vitamin D, and found they increased circulating 25(OH)D concentrations in a dose-dependent manner but identified a need for stronger data on the efficacy of vitamin D-fortified food on deficiency prevention and potential health outcomes, including adverse effects. Finally, narrative reviews provided estimates of the prevalence of inadequate intakes of vitamin D in adults and children from international dietary surveys, as well as a compilation of research requirements for vitamin D to inform current and future assessments of vitamin D requirements. [Supplementary materials are available for this article. Go to the publisher's onilne edition of Critical Reviews in Food Science and Nutrion for the following free supplemental files: Additional text, tables, and figures.].
Asunto(s)
Suplementos Dietéticos , Ingesta Diaria Recomendada/legislación & jurisprudencia , Vitamina D/sangre , Calcio de la Dieta/administración & dosificación , Calcio de la Dieta/sangre , Dieta , Medicina Basada en la Evidencia , Humanos , Metaanálisis como Asunto , National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division , Política Nutricional/legislación & jurisprudencia , Ensayos Clínicos Controlados Aleatorios como Asunto , Valores de Referencia , Medición de Riesgo , Estados Unidos , Vitamina D/farmacocinéticaRESUMEN
Zinc was selected as a priority micronutrient for EURRECA, because there is significant heterogeneity in the Dietary Reference Values (DRVs) across Europe. In addition, the prevalence of inadequate zinc intakes was thought to be high among all population groups worldwide, and the public health concern is considerable. In accordance with the EURRECA consortium principles and protocols, a series of literature reviews were undertaken in order to develop best practice guidelines for assessing dietary zinc intake and zinc status. These were incorporated into subsequent literature search strategies and protocols for studies investigating the relationships between zinc intake, status and health, as well as studies relating to the factorial approach (including bioavailability) for setting dietary recommendations. EMBASE (Ovid), Cochrane Library CENTRAL, and MEDLINE (Ovid) databases were searched for studies published up to February 2010 and collated into a series of Endnote databases that are available for the use of future DRV panels. Meta-analyses of data extracted from these publications were performed where possible in order to address specific questions relating to factors affecting dietary recommendations. This review has highlighted the need for more high quality studies to address gaps in current knowledge, in particular the continued search for a reliable biomarker of zinc status and the influence of genetic polymorphisms on individual dietary requirements. In addition, there is a need to further develop models of the effect of dietary inhibitors of zinc absorption and their impact on population dietary zinc requirements.
Asunto(s)
Suplementos Dietéticos , Ingesta Diaria Recomendada/legislación & jurisprudencia , Zinc/sangre , Disponibilidad Biológica , Biomarcadores/sangre , Dieta , Europa (Continente) , Humanos , Metaanálisis como Asunto , Evaluación Nutricional , Política Nutricional/legislación & jurisprudencia , Ensayos Clínicos Controlados Aleatorios como Asunto , Valores de Referencia , Zinc/farmacocinéticaRESUMEN
A key step toward developing appropriate evidence-based public health nutrition policies is determining exactly how that evidence should be collected and assessed. Despite this the extent to which different evidence bases influence policy selection is rarely explored. This article presents an epistemological framework which offers a range of considerations affecting this process generally and with particular implications for both micronutrient requirements and the role of behavior in the policy-making process. Qualitative case study data covering 6 European countries/regions (Czech Republic, Italy, the Netherlands, Nordic countries, Poland, and Spain), and three micronutrients (folate, iodine, and vitamin D), have been presented to illustrate the relevance of the Framework.
Asunto(s)
Política Nutricional/legislación & jurisprudencia , Formulación de Políticas , Salud Pública , Ingesta Diaria Recomendada/legislación & jurisprudencia , Suplementos Dietéticos , Europa (Continente) , Medicina Basada en la Evidencia , Humanos , Metaanálisis como Asunto , Micronutrientes/sangre , Estado NutricionalRESUMEN
The EURopean micronutrient RECommendations Aligned (EURRECA) Network of Excellence (NoE) explored an approach for setting micronutrient recommendations, which would address the variation in recommendations across Europe. Therefore, a framework for deriving and using micronutrient Dietary Reference Values (DRVs) has been developed. This framework comprises four stages (defining the problem-monitoring and evaluating-deriving dietary reference values-using dietary reference values in policy making). The aim of the present paper is to use this framework to identify specific research gaps and needs related to (1) knowledge available on specific micronutrients (folate, iodine, iron, selenium, vitamin B12, vitamin D, and zinc) and (2) the methodology presented in the framework. Furthermore, the paper describes the different outputs that support the process like protocols, guidelines, systematic review databases, and peer-reviewed publications, as well as the principal routes of dissemination of these outputs to ensure their optimal uptake in policy, practice, and research collaborations. The importance of ensuring transparency in risk assessment and risk management, systematic searching the literature, and taking into account policy options is highlighted. [Supplementary materials are available for this article. Go to the publisher's online edition of Critical Reviews in Food Science and Nutrition for the following free supplemental files: Additional tables.].
Asunto(s)
Micronutrientes/sangre , Política Nutricional/tendencias , Ingesta Diaria Recomendada/tendencias , Dieta/normas , Dieta/tendencias , Relación Dosis-Respuesta a Droga , Europa (Continente) , Medicina Basada en la Evidencia , Humanos , Metaanálisis como Asunto , Política Nutricional/legislación & jurisprudencia , Estado Nutricional , Estudios Observacionales como Asunto , Ensayos Clínicos Controlados Aleatorios como Asunto , Ingesta Diaria Recomendada/legislación & jurisprudenciaRESUMEN
No disponible